AR015820A1 - Particulas de budesonida, composicion farmaceutica, uso de dichas particulas para la fabricacion de medicamentos, metodo para el tratamiento de untrastorno respiratorio y proceso para la preparacion de las particulas - Google Patents
Particulas de budesonida, composicion farmaceutica, uso de dichas particulas para la fabricacion de medicamentos, metodo para el tratamiento de untrastorno respiratorio y proceso para la preparacion de las particulasInfo
- Publication number
- AR015820A1 AR015820A1 ARP980102400A ARP980102400A AR015820A1 AR 015820 A1 AR015820 A1 AR 015820A1 AR P980102400 A ARP980102400 A AR P980102400A AR P980102400 A ARP980102400 A AR P980102400A AR 015820 A1 AR015820 A1 AR 015820A1
- Authority
- AR
- Argentina
- Prior art keywords
- particles
- treatment
- manufacture
- preparation
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Partículas finamente divididas, sustancialmente cristalinas de budesonida que son sustancialmente blandas y tienen un valor BET (absorcion de gas) entre 1hasta 4,5 m2/g, el proceso para su preparacion, una composicion farmacéutica que comprende adic has partículas, el uso de dichas partículas para el tratamientoy la fabricacion de un medicamento para usar en el tratamiento de trastornos respiratorios y un método para el tratamiento de trastornos respiratorios pormedio de la administracionde dic has partículas, a un huésped que necesita dicho tratamiento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9701956A SE9701956D0 (sv) | 1997-05-23 | 1997-05-23 | New composition of matter |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015820A1 true AR015820A1 (es) | 2001-05-30 |
Family
ID=20407079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102400A AR015820A1 (es) | 1997-05-23 | 1998-05-22 | Particulas de budesonida, composicion farmaceutica, uso de dichas particulas para la fabricacion de medicamentos, metodo para el tratamiento de untrastorno respiratorio y proceso para la preparacion de las particulas |
Country Status (28)
Country | Link |
---|---|
US (2) | US6346523B1 (es) |
EP (1) | EP1005328B1 (es) |
JP (1) | JP2001525850A (es) |
KR (1) | KR100514971B1 (es) |
CN (1) | CN1146406C (es) |
AR (1) | AR015820A1 (es) |
AT (1) | ATE246492T1 (es) |
AU (1) | AU734763B2 (es) |
BR (1) | BR9808812A (es) |
CA (1) | CA2290538C (es) |
DE (1) | DE69816997T2 (es) |
DK (1) | DK1005328T3 (es) |
EE (1) | EE03850B1 (es) |
ES (1) | ES2205496T3 (es) |
HU (1) | HUP0002212A3 (es) |
ID (1) | ID24332A (es) |
IL (1) | IL133098A (es) |
IS (1) | IS5254A (es) |
NO (1) | NO995540D0 (es) |
NZ (1) | NZ500852A (es) |
PL (1) | PL336902A1 (es) |
PT (1) | PT1005328E (es) |
SE (1) | SE9701956D0 (es) |
SK (1) | SK158799A3 (es) |
TR (1) | TR199902880T2 (es) |
TW (1) | TW518236B (es) |
WO (1) | WO1998052544A1 (es) |
ZA (1) | ZA984127B (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4990696A (en) * | 1995-02-24 | 1996-09-11 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
EP1263516A1 (en) * | 2000-03-03 | 2002-12-11 | Boehringer Ingelheim Pharmaceuticals Inc. | Material processing by repeated solvent expansion-contraction |
CA2433169A1 (en) * | 2000-12-26 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Porous substances and methods for producing the same |
GB0106403D0 (en) * | 2001-03-15 | 2001-05-02 | Pharmaceutical Profiles | Labelling of dry powder formulations for inhalation |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
JP2004537401A (ja) | 2001-08-08 | 2004-12-16 | ブラウン ユニバーシティ リサーチ ファウンデーション | 疎水性薬物の微粉砕方法 |
RS29104A (en) | 2001-10-10 | 2006-12-15 | Boehringer Ingelheim Pharmaceuticals Inc. | Powder processing with pressurized gaseous fluids |
US20030129242A1 (en) * | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
GB0216562D0 (en) * | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
WO2004105809A1 (en) | 2003-05-22 | 2004-12-09 | Elan Pharma International Ltd. | Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
DE602004023765D1 (de) * | 2004-03-12 | 2009-12-03 | Trinity College Dublin | Magnetoresistives medium |
CN101312713A (zh) * | 2005-03-18 | 2008-11-26 | 纳米材料科技有限公司 | 可吸入的药物 |
WO2007009164A1 (en) | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Method of particle formation |
EP1782839A1 (en) | 2005-11-03 | 2007-05-09 | Genetic S.p.A. | Sterilization process of Glucocorticosteroid by supercritical CO2 |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070178051A1 (en) * | 2006-01-27 | 2007-08-02 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
EP1988878A2 (en) * | 2006-02-15 | 2008-11-12 | Tika Läkemedel AB | Sterilization of corticosteroids with reduced mass loss |
ES2691033T3 (es) | 2007-02-11 | 2018-11-23 | Map Pharmaceuticals Inc. | Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios |
US20100298602A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Systems and methods for microfluidic crystallization |
US20100294986A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Supercritical fluid facilitated particle formation in microfluidic systems |
US8574630B2 (en) * | 2010-09-22 | 2013-11-05 | Map Pharmaceuticals, Inc. | Corticosteroid particles and method of production |
CN102975731B (zh) * | 2012-04-24 | 2015-08-12 | 南车南京浦镇车辆有限公司 | 轨道车辆司机室骨架与车体的安装结构 |
WO2021219230A1 (en) | 2020-04-30 | 2021-11-04 | Paolo Fiorina | Antiviral treatment |
KR102567655B1 (ko) | 2020-11-13 | 2023-08-17 | 주식회사 비츠로이엠 | 진공커패시터 및 진공커패시터 제조 방법 |
KR20230072022A (ko) | 2021-11-17 | 2023-05-24 | 주식회사 비츠로이엠 | 가변형 진공 커패시터 |
KR20230072023A (ko) | 2021-11-17 | 2023-05-24 | 주식회사 비츠로이엠 | 가변형 진공 커패시터의 나선형 전극 위치 결정구조 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1282405C (en) | 1984-05-21 | 1991-04-02 | Michael R. Violante | Method for making uniformly sized particles from water-insoluble organic compounds |
WO1990003782A2 (en) | 1988-10-05 | 1990-04-19 | The Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
GB9001635D0 (en) | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
ES2078447T3 (es) | 1990-06-15 | 1995-12-16 | Merck & Co Inc | Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales. |
US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
ATE213946T1 (de) * | 1991-12-18 | 2002-03-15 | Formoterol und budesonide enthaltende zusammensetzung | |
GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
SE9501384D0 (sv) | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
-
1997
- 1997-05-23 SE SE9701956A patent/SE9701956D0/xx unknown
-
1998
- 1998-05-15 AT AT98924697T patent/ATE246492T1/de not_active IP Right Cessation
- 1998-05-15 TR TR1999/02880T patent/TR199902880T2/xx unknown
- 1998-05-15 ID IDW991396A patent/ID24332A/id unknown
- 1998-05-15 DE DE69816997T patent/DE69816997T2/de not_active Expired - Lifetime
- 1998-05-15 NZ NZ500852A patent/NZ500852A/en unknown
- 1998-05-15 SK SK1587-99A patent/SK158799A3/sk unknown
- 1998-05-15 IL IL13309898A patent/IL133098A/xx not_active IP Right Cessation
- 1998-05-15 AU AU76800/98A patent/AU734763B2/en not_active Ceased
- 1998-05-15 CN CNB988053381A patent/CN1146406C/zh not_active Expired - Fee Related
- 1998-05-15 ES ES98924697T patent/ES2205496T3/es not_active Expired - Lifetime
- 1998-05-15 KR KR10-1999-7010785A patent/KR100514971B1/ko not_active IP Right Cessation
- 1998-05-15 PT PT98924697T patent/PT1005328E/pt unknown
- 1998-05-15 EE EEP199900533A patent/EE03850B1/xx not_active IP Right Cessation
- 1998-05-15 CA CA002290538A patent/CA2290538C/en not_active Expired - Fee Related
- 1998-05-15 HU HU0002212A patent/HUP0002212A3/hu unknown
- 1998-05-15 WO PCT/SE1998/000908 patent/WO1998052544A1/en active IP Right Grant
- 1998-05-15 BR BR9808812-2A patent/BR9808812A/pt not_active Application Discontinuation
- 1998-05-15 ZA ZA984127A patent/ZA984127B/xx unknown
- 1998-05-15 EP EP98924697A patent/EP1005328B1/en not_active Expired - Lifetime
- 1998-05-15 TW TW087107532A patent/TW518236B/zh not_active IP Right Cessation
- 1998-05-15 PL PL98336902A patent/PL336902A1/xx unknown
- 1998-05-15 DK DK98924697T patent/DK1005328T3/da active
- 1998-05-15 JP JP55028498A patent/JP2001525850A/ja not_active Ceased
- 1998-05-15 US US09/091,453 patent/US6346523B1/en not_active Expired - Fee Related
- 1998-05-22 AR ARP980102400A patent/AR015820A1/es not_active Application Discontinuation
-
1999
- 1999-11-12 NO NO995540A patent/NO995540D0/no not_active Application Discontinuation
- 1999-11-18 IS IS5254A patent/IS5254A/is unknown
-
2001
- 2001-11-06 US US09/992,940 patent/US6468994B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR015820A1 (es) | Particulas de budesonida, composicion farmaceutica, uso de dichas particulas para la fabricacion de medicamentos, metodo para el tratamiento de untrastorno respiratorio y proceso para la preparacion de las particulas | |
TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
AR013614A1 (es) | Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento | |
IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
BR0008699A (pt) | Combinações de formoterol e furoato demometasona para asma | |
CA2392879A1 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
PT1326595E (pt) | Composicao farmaceutica compreendendo resveratrol para o tratamento de disturbios respiratorios inflamatorios | |
SE9802073D0 (sv) | New use | |
ATE99941T1 (de) | Medikamente enthaltend salmeterol und fluticason. | |
MY129512A (en) | Novel medicament compositions, based on tiotropium bromide and salmeterol | |
KR960703009A (ko) | 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용 | |
WO1994008551A3 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
EE200300514A (et) | Ftalasinoonid, nende kasutamine hingamisteede haigusnähte leevendavate ravimite valmistamiseks ningneid sisaldavad ravimid | |
AR039408A1 (es) | Composicion farmaceutica en polvo seco para terapia por inhalacion y uso para fabricacion de un medicamento | |
DK0416950T3 (da) | Medikamenter | |
BR0312619A (pt) | Composição farmacêutica, método para formular uma composição de modafinil, unidade de dosagem farmacêutica, e, métodos para alterar o estado sonolento de um mamìfero, intensificar a condição de atividade ou aumentar a regularidade da periodicidade do sono | |
EE03204B1 (et) | Toimeaine flupirtiini kasutamine ravimi valmistamiseks | |
DE69200711D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung. | |
AR021086A1 (es) | Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento. | |
BR0309114A (pt) | Uso de carboidratos derivados particulados em composições farmacêuticas em pó seco, composição farmacêutica em pó seco para terapia de inalação, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, e, embalagem de medicamento | |
JPS52130922A (en) | Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |